FilingReader Intelligence

Hengrui Pharmaceuticals increases stake in subsidiary for 4m yuan

July 25, 2025 at 05:08 PM UTC•By FilingReader AI

Jiangsu Hengrui Medicine will acquire an additional 1.4587% equity stake in its controlled subsidiary, Chengdu Shengdi Pharmaceutical, for 4 million yuan.

The transaction will increase Hengrui's ownership from 95.93% to 97.39%. The company said the move will have no significant impact on financial results.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Asset valuation report for Hengrui Pharmaceuticals' proposed acquisition of a partial equity stake in Chengdu Shengdi Pharmaceutical Co., Ltd.July 25, 2025 at 08:00 AM UTC

Supplementary Source Documents

Announcement by Hengrui Pharmaceuticals regarding the acquisition of minority shareholder equity in a controlled subsidiary and related party transactionJuly 25, 2025 at 08:00 AM UTC

Jiangsu Hengrui Medicine

SSE:600276•Shanghai Stock Exchange

Shanghai Blue Chip

RSS feed for Jiangsu Hengrui Medicine

News Alerts

Get instant email alerts when Jiangsu Hengrui Medicine publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →